New drug combo offers hope for older hodgkin lymphoma patients unsuitable for standard chemo
NCT ID NCT02758717
Summary
This study is testing a combination of two immunotherapy drugs, nivolumab and brentuximab vedotin, for older adults or those who cannot tolerate standard chemotherapy for untreated Hodgkin lymphoma. The goal is to see how well this drug combination controls the cancer by helping the immune system attack it and stopping cancer cell growth. Researchers will measure how many patients respond to treatment and how long the response lasts.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANN ARBOR STAGE IB HODGKIN LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Emory University Hospital/Winship Cancer Institute
Atlanta, Georgia, 30322, United States
-
Hackensack University Medical Center
Hackensack, New Jersey, 07601, United States
-
Laura and Isaac Perlmutter Cancer Center at NYU Langone
New York, New York, 10016, United States
-
M D Anderson Cancer Center
Houston, Texas, 77030, United States
-
Mayo Clinic
Rochester, Minnesota, 55905, United States
-
MedStar Georgetown University Hospital
Washington D.C., District of Columbia, 20007, United States
-
Ohio State University Comprehensive Cancer Center
Columbus, Ohio, 43210, United States
-
Stanford Cancer Institute Palo Alto
Palo Alto, California, 94304, United States
-
Washington University School of Medicine
St Louis, Missouri, 63110, United States
Conditions
Explore the condition pages connected to this study.